Evidence map›Paper›PMID 42532553›Full record

ArticleChemMedChem2026

Fragmentation of Vancoresmycin Reveals a Strong Dependence on Global Molecular Architecture for Antibacterial Activity.

Max Schönenbroicher, Florian Heppner, Maximilian Seul, Simon Morgenschweis, Aia Ali Abdelrahman, Eva Fahr, Niklas Holstein, Anna Müller, Dirk Menche

Abstract read
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Max SchönenbroicherKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0005-3277-0805
Florian HeppnerKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0003-2930-5019
Maximilian SeulKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn, Germany.
Simon MorgenschweisKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn, Germany.
Aia Ali AbdelrahmanInstitute of Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Eva FahrInstitute of Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn, Bonn, Germany.
Niklas HolsteinInstitute of Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0009-0004-3134-9341
Anna MüllerInstitute of Pharmaceutical Microbiology, University Hospital Bonn, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0001-6420-3868
Dirk MencheKekulé-Institute for Organic Chemistry and Biochemistry, University of Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-4724-8383

Funding

Deutsche Forschungsgemeinschaft GRK 2873-494832089Fonds der Chemischen Industrie stipends to F.H. and A.M.Jürgen Manchot Stiftung stipend to S.M.
6 · The paper itself

Abstract

Vancoresmycin is a structurally complex tetramic-acid-containing natural product with potent activity against Gram-positive bacteria, yet its structure-activity relationships remain poorly defined. In particular, it is unclear whether discrete substructures contribute independently to antibacterial activity or whether biological function depends on the integrity of the full molecular framework. Here, we report the synthesis and biological evaluation of a series of structurally defined fragments derived from vancoresmycin and its aglycon amycomycin, including the tetramic acid core, eastern and western polyketide segments, and the mycosamine residue. Despite preserving key structural motifs, the fragments did not exhibit considerable antibacterial activity. Only the western fragment displayed weak activity accompanied by indications of membrane-associated stress. These results demonstrate that antibacterial activity in vancoresmycin cannot be attributed to isolated substructures but instead depends on the integrated molecular architecture. These results provide a framework for future design strategies that preserve global structural properties rather than focusing on discrete motifs.

Indexed as

Anti-Bacterial AgentsGram-Positive BacteriaPyrrolidinonesDose-Response Relationship, DrugMicrobial Sensitivity TestsMolecular StructureStructure-Activity RelationshipAnti-Bacterial AgentsPyrrolidinonestetramic acidamycomycinantibioticstetramic acidsvancoresmycin

Identifiers

PMID42532553
PMCPMC13423584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.